Misuse of antithrombotic therapy in atrial fibrillation patients: frequent, pervasive and persistent.
Fornari, Luciana S; Calderaro, Daniela; Nassar, Ivana B; Lauretti, Cristiane; Nakamura, Lidia; Bagnatori, Renato; Ageno, Walter; Caramelli, Bruno.
J Thromb Thrombolysis
; 23(1): 65-71, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17186395
Concomitant atrial fibrillation surgery for people undergoing cardiac surgery.
Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation.
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Preoperative Use of Oral Beta-Adrenergic Blocking Agents and the Incidence of New-Onset Atrial Fibrillation After Cardiac Surgery. A Systematic Review and Meta-Analysis.
Meta-Analysis of Efficacy and Safety of Apixaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs.
Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice.
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.
Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.